Literature DB >> 18000735

Pathophysiology of obesity: why surgery remains the most effective treatment.

Talat Waseem1, Kris M Mogensen, David B Lautz, Malcolm K Robinson.   

Abstract

Obesity is a rapidly increasing, worldwide epidemic. Despite recent scientific advances, no currently recommended dietary program or medication results in long-term weight loss of more than 10% of body weight for the vast majority of people who attempt these interventions. Hence, surgical intervention is recommended for patients with a BMI > or =40 kg/m2. Although surgery is an effective, sustainable treatment of obesity, it can be associated with potentially significant perioperative risks and long-term complications. Current research is focused on developing a medical therapy, which produces more effective and sustainable weight loss, yet avoids the risks inherent in major surgery. With a reduced risk profile, such therapy could also be appropriately offered to those who are less obese and, in theory, help those who have BMIs as low as 27 kg/m2. Toward that end, numerous scientists are working to both unravel the pathophysiology of obesity and to determine why surgical intervention is so effective. This review briefly examines the current status of obesity pathophysiology and management, the reasons for failure of conventional medical treatments, and the success of surgical intervention. Finally, future areas of research are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000735     DOI: 10.1007/s11695-007-9220-1

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  80 in total

Review 1.  Role of hypothalamic neuropeptide Y in feeding and obesity.

Authors:  D R Gehlert
Journal:  Neuropeptides       Date:  1999-10       Impact factor: 3.286

Review 2.  Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss?

Authors:  David E Cummings; Michael H Shannon
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

3.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty.

Authors:  J M Kellum; J F Kuemmerle; T M O'Dorisio; P Rayford; D Martin; K Engle; L Wolf; H J Sugerman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

4.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

5.  Gastric bypass.

Authors:  E E Mason; C Ito
Journal:  Ann Surg       Date:  1969-09       Impact factor: 12.969

6.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

Review 7.  Gastrointestinal hormones and food intake.

Authors:  April D Strader; Stephen C Woods
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

Review 8.  Current status of medical and surgical therapy for obesity.

Authors:  E C Mun; G L Blackburn; J B Matthews
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

9.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

10.  Gastric bypass versus gastroplasty. A prospective study of differences in two surgical procedures for morbid obesity.

Authors:  I Näslund
Journal:  Acta Chir Scand Suppl       Date:  1987
View more
  9 in total

1.  Wide topical negative pressure wound dressing treatment for patients undergoing abdominal dermolipectomy following massive weight loss.

Authors:  Adrian Dragu; Stefan Schnürer; Frank Unglaub; Maya B Wolf; Justus P Beier; Ulrich Kneser; Raymund E Horch
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

2.  500 intragastric balloons: what happens 5 years thereafter?

Authors:  Katerina Kotzampassi; Vasilis Grosomanidis; Pyrros Papakostas; Sofia Penna; Efthymios Eleftheriadis
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

3.  Hematological variables and iron status in abdominoplasty after bariatric surgery.

Authors:  Juan Carlos Montano-Pedroso; Elvio Bueno Garcia; Ivan Rene Viana Omonte; Mario Guilherme Cesca Rocha; Lydia Masako Ferreira
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

4.  Early and long-term clinical outcomes of bilio-intestinal diversion in morbidly obese patients.

Authors:  Alessandro De Cesare; Barbara Cangemi; Enrico Fiori; Marco Bononi; Roberto Cangemi; Luigi Basso
Journal:  Surg Today       Date:  2014-02-12       Impact factor: 2.549

5.  Obesity stigma: important considerations for public health.

Authors:  Rebecca M Puhl; Chelsea A Heuer
Journal:  Am J Public Health       Date:  2010-01-14       Impact factor: 9.308

6.  Scientific decision making, policy decisions, and the obesity pandemic.

Authors:  James R Hebert; David B Allison; Edward Archer; Carl J Lavie; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2013-06       Impact factor: 7.616

7.  Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.

Authors:  Eric D Labonté; Lisa M Camarota; Juan C Rojas; Ronald J Jandacek; Dean E Gilham; Joanna P Davies; Yiannis A Ioannou; Patrick Tso; David Y Hui; Philip N Howles
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

8.  Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

Review 9.  Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches.

Authors:  Dragana Nikolic; Niki Katsiki; Giuseppe Montalto; Esma R Isenovic; Dimitri P Mikhailidis; Manfredi Rizzo
Journal:  Nutrients       Date:  2013-03-18       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.